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Background: Iron in the overloaded condition in liver promotes the overproduction of free radicals that lead to
oxidative stress and ultimately hepatic damage. The present study was designed to evaluate the ameliorating
potential from iron overloaded hepatotoxicity by the glycosidic fraction from Spondious pinnata bark (SPW1) along
with its antioxidant property.
Methods: The fraction was tested for its in vitro antioxidant, free radical scavenging property and iron chelation
potential via standard biochemical assays. Iron overload condition was generated by the intraperitoneal
administration of iron dextran in mice. The levels of serum enzymes, antioxidant enzymes in liver, markers of
hepatic damage, liver iron, and ferritin content were measured in response to the oral treatment of SPW1.
Histopathology of the liver sections was performed for visual confirmation of the amelioration potential of SPW1.
Results: The fraction exhibited excellent in vitro antioxidant as well as free radical scavenging potential against
both reactive oxygen species and reactive nitrogen species. Administration of SPW1 significantly normalized the
disturbed levels of antioxidant enzymes, liver iron, lipid peroxidation, liver fibrosis, serum enzyme and ferritin better
than standard desirox which were also supported by the morphological study of the liver sections. Phytochemical
analysis as well as HPLC study, confirmed that the fraction mainly consisted of glycosidic phenolics and flavonoids
that attributed to its biological activities.
Conclusions: The above results suggested that beneficial effects of SPW1 on iron overload induced hepatotoxicity
that can be considered as a possible candidate against iron overload diseases.
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Liver, the largest glandular organ in the body, plays a dy-
namic role in metabolism, biotransformation of proteins,
carbohydrates, lipids and also detoxification of different
endogenous and exogenous xenobiotics and drugs.
Hence, the liver is liable to injury due to the chronic ex-
posure to environmental toxicants, drugs and other xe-
nobiotics [1]. Nowadays, iron overload mediated
disorders like liver fibrosis, cirrhosis, inflammation,* Correspondence: mandaln@rediffmail.com
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cancer [2], are common throughout the world occurring
mostly in major race/ethnic groups [3]. Moreover, iron
overloaded toxicity caused a major problem in thalasse-
mic patients than other type of liver toxicity. Although,
iron, one of the most important redox metals, is essen-
tial for different cellular processes as there is a close re-
lationship between iron essentiality and iron toxicity.
Excess iron causes a serious damage to the liver that is
the main storage site of iron in our body, by forming hy-
droxyl radical mediated oxidative stress. So, protection
against metal toxicity by chelating metal ions or byle is distributed under the terms of the Creative Commons Attribution 4.0
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saving strategy for nearly all the iron overload-induced
diseases mentioned above [4]. In addition to endogenous
antioxidant systems, consumption of natural supple-
ments that is rich in natural antioxidants also exhibits
increased resistance to oxidative stress by altering the
redox environment and is associated with a lower risk of
many oxidative stress-related diseases.
Different phytochemicals mainly natural water soluble
phenolics and flavonoids are used to treat iron-induced
liver toxicity as they can efficiently scavenge most of the
free radicals through their relevant iron chelating
capabilities. From the previous publications, it was ob-
served that 70 % methanol extract of Spondias pinnata
(Linn. f.) Kurz (Fam. Anacardiaceae) possessed both
in vitro & in vivo antioxidant and iron-chelating poten-
tial, which was supported by the presence of significant
amounts of phenolics and flavonoids [5, 6]. These previ-
ous studies prompted us to separate the water soluble
glycosidic compounds from S. pinnata bark and evaluate
their ameliorating effect on iron overload-induced hep-




(ABTS) was purchased from Roche diagnostics,
Germany and 6-hydroxy-2,5,7,8-tetramethylchroman-
2-carboxylic acid (Trolox) was obtained from Fluka,
Switzerland. Bathophenanthrolinesulfonate disodium
salt, 5,5′-dithiobis-2-nitrobenzoic acid (DTNB) and N-
(1-Naphthyl) ethylenediaminedihydrochloride (NED)
were procured from Sisco Research Laboratories Pvt. Ltd,
India. 1-chloro-2,4-dinitrobenzene (CDNB), Dimethyl-4-
aminobenzaldehyde, and N,N- dimethyl-4-nitrosoaniline
ammonium iron (II) sulfate hexahydrate ((NH4)2Fe(SO4)2,
6H2O) were obtained from Merck, Mumbai, India. Guan-
idine hydrochloride and Iron-dextran was purchased from
Sigma-Aldrich, USA. Desirox (Deferasirox) was obtained
from Cipla Ltd., India. All of the other used reagents were
of molecular biology grade and were obtained from reput-
able suppliers.
Test animals
In vivo experiments were performed abiding by the
guidelines of the Committee for the Purpose of Control
and Supervision of Experiments on Animals (CPCSEA),
Ministry of Environment and Forest, Govt. of India with
due approval from the Institutional Animal Ethics
Committee, Bose Institute (Registration. No. 95/1999/
CPCSEA). Male Swiss albino mice (20 ± 2 g) were ob-
tained from the Chittaranjan National Cancer Institute
(CNCI), Kolkata, India and were acclimated under a
constant 12 h light / dark cycle at 22 ± 2 °C. The animalswere fed general laboratory diet and water ad libitum.
Experimental animals were taken care every six hour
during the treatment period, and it was observed that
there was no unwanted animal death. All surgeries were
done using ethyl ether as an anesthetic, taking utmost
care to reduce suffering.
Plant material
S. pinnata bark was collected from the villages of
Bankura district, West Bengal, India and the plant was
authenticated by Dr. Jayaram Hazra, Director, Central
Research Institute of Ayurveda (CRIA), Kolkata, India.
The herbarium was submitted at CRIA, Kolkata with an
accession no of CRHS 111/08.
Fractionation of crude extract
The powdered S. pinnata stem bark was extracted with
70 % methanol and water [5]. The lyophilized extract
was re-extracted successively with hexane, chloroform,
ethyl acetate and water. The water fraction again frac-
tionated by acetylation (2 ml of pyridine and 2 ml of
acetic anhydride was stirred with 500 mg of water frac-
tion at 40 °C for 6 h) followed by silica gel column chro-
matography purification (major spot) and deacetylation
(150 mg of sodium methoxide was stirred with 500 mg
of acetylated product dissolved in 50 % methanol in di-




Antioxidant capacities of SPW1 was evaluated by
ABTS•+ radical cation decolorization assay, DPPH
(2,2-diphenyl-1-picrylhydrazyl) scavenging assay, and
Fe3+-reducing power assay according to a standard
method [5]. The scavenging percentage was quantified
using test and control experiment values.
Free radical scavenging activity
In vitro reactive oxygen species (ROS) scavenging prop-
erties were determined by superoxide, hydroxyl, hypo-
chlorous and singlet oxygen radical scavenging assays,
and reactive nitrogen species (RNS) scavenging activity
was determined by nitric oxide and peroxynitrite radical
scavenging assays following standard procedures [5].
In vitro iron chelation and ferritin iron release
The Fe2+ chelating ability was determined as described
earlier, and the result was expressed as inhibition per-
centage [5]. Iron reduction and release were determined
using ferrozine, a spectrophotometric reagent for iron,
as previously described [7]. Briefly, the reaction was
initiated by adding different concentrations (100–500 μg/
ml) of test compounds in 50 mM phosphate buffer
Chaudhuri et al. BMC Complementary and Alternative Medicine  (2016) 16:262 Page 3 of 12(pH 7.0) containing 200 μg ferritins and 500 μM ferrozine,
and the absorbance change was measured for 20 min at
560 nm.In vivo study
Experimental design
In total, six groups of mice were randomly prepared to
consist of six mice per group. Among them, one group
received normal saline only, which was labeled as a
blank (B); however, other groups were intoxicated with
five doses of 100 mg/kg b.w. iron-dextran (one dose
every alternative day) by intraperitoneal injection (ip).
Of the groups, one iron-dextran group (C) was treated
orally with the only saline, and other groups were
treated with 50 mg/kg b.w SPW1 (S50), 100 mg/kg b.w.
SPW1 (S100), 200 mg/kg b.w. SPW1 (S200), test sam-
ples and 20 mg/kg b.w. desirox (D) for 21 consecutive
days starting on the day following the first iron-dextran
injection. The doses of SPW1 were selected on the basis
of the obtained LD50 value (1309 mg/kg b.w.). All ex-
perimental animals were sacrificed on the 22nd day
under mild anesthesia (ethyl ether), and the cardiac
puncture was performed to collect blood and serum was
separated and stored at −80 °C. After collecting the
blood, the liver was quickly excised, cleaned thoroughly
with cold phosphate buffer saline (PBS) to remove the
remaining blood and cut into three sections. The major
liver portion was dissected and homogenized using 10
volumes of 0.1 M phosphate buffer (pH 7.4) supple-
mented with 0.15 M NaCl and 5 mM EDTA and centri-
fuged for 30 min at 8000 g in the cold. The clear
homogenate (supernatant) was collected and the protein
concentration was quantified by the Folin-Lowry method,
where BSA was used as a standard; the remaining
supernatant was then stored at −80 °C. The second
liver fragment was treated with a mixture of nitric
acid and sulfuric acid (1:1) to analyze the iron con-
tent. The last portion was processed for histopatho-
logical examinations. This procedures were performed
according to pervious method [6].Serum markers
Aspartate aminotransferase (ASAT), alanine aminotrans-
ferase (ALAT), and bilirubin levels in serum were evalu-
ated using commonly available kits from Merck, India.
Similarly, alkaline phosphatase (ALP) levels were mea-
sured by a kit from Sentinel Diagnostics, Italy.Antioxidant enzymes
Superoxide dismutase (SOD), catalase (CAT), glutathione-
S-transferase (GST), and reduced glutathione (GSH) levels
were measured using previously described methods [6].Evaluation of liver damage and fibrosis
Thiobarbituric acid reactive substances (TBARS) quan-
tities were measured to evaluate the levels of lipid perox-
idation. Protein oxidation levels were resolved by
estimating protein carbonyl contents. Collagen content,
an important marker of liver fibrosis in each sample was
determined by multiplying 7.69 to overall hydroxypro-
line content. These values were measured using previ-
ously described methods [6].
Serum ferritin and liver iron levels
Manufacturer’s instructions were followed to quantify
serum ferritin levels using an ELISA kit from Monobind
Inc., USA. Liver iron content was quantified using a pre-
viously reported method [6]. Briefly, samples were mixed
with bathophenanthroline sulfonate and incubated at
37 °C for 30 min, and absorbance was recorded using a
spectrophotometer at 535 nm.
Histopathological studies
Excised liver samples were cleaned with saline and fixed
for two days in 10 % buffered neutral formalin. Sections
(5 μm thick) were paraffin-embedded and stained with
hematoxylin and eosin (morphological examination),
Perls’ Prussian blue dye (iron content) and Masson’s tri-
chrome stain (liver fibrosis). Stained sections were
checked microscopically for histopathological changes.
Phytochemical analysis
The presence of phytochemicals was evaluated following
different standard methods [8, 9]. HPLC analysis was
performed according to the previous method to identify
the bioactive phytochemicals [10] present in SPW1.
Statistical analysis
All of the data were reported as the mean ± SD of six
measurements. Statistical analysis was performed using
KyPlot version 2.0 beta 15 (32 bit) and Microsoft Excel
2010. The relationships between the groups were evalu-
ated using a paired t-test, and a p value of <0.05 was
considered to be statistically significant.
Results
Fractionation of extract
The polarity based fractionation by different solvents re-
vealed that the water fraction yielded more than 90 % of
the total extract, indicating the fact that the activity of
the crude extract was mainly due to water soluble polar
compounds. Further to regroup the probable glycosidic
compounds in water fraction, it was acetylated to con-
vert the polar acid groups into non-polar acetyl group.
This process would facilitate the separation of the simi-
lar group of compounds through silica gel chromatog-
raphy. The major spot, among the other several minor
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and further deacetylated to remove the acetyl groups to
revert the native free carboxylic acid groups of the com-
pounds in that fraction.
In vitro study
Antioxidant potentials
The overall picture of the antioxidative ability of SPW1
was evaluated by ABTS•+ radical cation scavenging,
DPPH radical scavenging and reducing power capacity
assays. It was observed that SPW1 possessed excellent
total antioxidant capacity that is almost similar to the
standard Trolox (Fig. 1a). Similarly the fraction also
strongly scavenge DPPH radical as well as reduce the
Fe3+ to Fe2+ by donating an electron which also support
the antioxidative capacity of SPW1 (Fig. 1b, c respect-
ively). The TEAC and the IC50 values listed in Table 1.
Free radical scavenging activity
The free radicals scavenging activity of the fraction
SPW1 against different ROS & RNS was depicted in the
Fig. 2, and the IC50 values were listed in Table 1. From
the Fig. 2 it was clear that the fraction scavenged/inhib-
ited different ROS, and RNS especially superoxide, hypo-
chlorous acid, peroxynitrite radicals since the activity of
the fraction was better than the standards (Fig. 2a, c, f
respectively). On the other hand, SPW1 exhibited mod-
erate activity against singlet oxygen and nitric oxide
radicals (Fig. 2d, e respectively) but failed to scavenge
hydroxyl radical (Fig. 2b).
In vitro iron chelation and ferritin iron release
Iron (Fe2+) chelation capability of SPW1 was determined
by hindering the development of violet colored Fe2+-fer-
rozine (Fig. 3a). At the highest tested concentration,
SPW1 disrupted the complex color formation up to 68 %.
From the Fig. 3b it was observed that SPW1 effectively re-
leased iron (Fe3+) from ferritin dose-dependently and also
displayed significant positive correlation (R2 = 0.8041)Fig. 1 Antioxidant potentials of SPW1. a Total antioxidant assay, b DPPH ra
the mean ± S.D. (n = 6). ***p < 0.001 vs. controlbetween the reducing power and (%) the iron released
from ferritin (Fig. 3c).
In vivo study
Liver iron and serum ferritin levels
The iron overload condition was measured directly by
the amount of iron in the liver and indirectly by ferritin
content in serum. Compared to the normal mice the
iron content (686 %) and serum ferritin (143 %) was ele-
vated due to iron overload but on treatment with SPW1
reverted the iron content as well as ferritin content al-
most to the levels of normal mice (Fig. 4a, b respect-
ively) and the EC50 values were listed in Table 2.
Serum markers
Intoxication with iron in mice liver elevated the serum
ALAT, ASAT, ALP and bilirubin that denoted hepatic
injury. As per Table 3, the levels of serum markers grad-
ually dropped dose-dependently at the individual level
on treatment with SPW1 and the EC50 values were listed
in Table 2.
Antioxidant enzymes
Iron in overloaded condition induced oxidative stress
and reduced the levels of antioxidant enzymes. After the
treatment with SPW1, the dropped levels of SOD
(89 %), Catalase (73 %), GST (72 %), GSH (37 %) were
dose-dependently restored nearly to the normal condi-
tion (Fig. 5a, b, c, d respectively) and the EC50 values
were listed in Table 2. The effect of restoring the anti-
oxidant enzymes level by SPW1 is better than desirox.
Evaluation of liver damage and fibrosis
The effect of iron overload on liver damage was mea-
sured by the level of lipid peroxidation, protein carbonyl
and collagen content in the liver homogenate. The in-
creased levels of these liver damage and fibrosis markers
were reduced after oral administration of SPW1 (Fig. 6a,
b, c respectively) and the EC50 values were listed in
Table 2.dical scavenging assay, c Reducing power assay. The results represent
Table 1 IC50 values of the SPW1 and standard compounds for different antioxidant, free radical and metal chelation assays
Name of assay SPW1 Standards Values of standard compounds
DPPH 50.76 ± 1.49 Ascorbic acid 5.29 ± 0.28
Superoxide anion (O2•
−) scavenging 8.95 ± 0.29 Quercetin 42.06 ± 1.35
Hydroxyl radical (OH•) scavenging 7244.91 ± 905.97 Mannitol 571.45 ± 20.12
Hypochlorous acid (HOCl) scavenging 66.05 ± 1.92 Ascorbic acid 235.96 ± 5.75
Singlet oxygen (1O2) scavenging 202.81 ± 7.95 Lipoic acid 46.15 ± 1.16
Nitric oxide radical (NO) scavenging 121.55 ± 5.01 Curcumin 90.82 ± 4.75
Peroxynitrite (ONOO-) scavenging 403.17 ± 8.01 Gallic acid 876.24 ± 56.96
Iron chelating activity 59.98 ± 0.67 EDTA 1.27 ± 0.05
All the values are expressed in μg/ml. Data expressed as mean ± S.D (n = 6). EDTA represents Ethylenediamine tetraacetic acid
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Liver sections stained with hematoxylin and eosin from
normal mice demonstrated normal cell morphology with
prominent nuclei in the well-preserved cytoplasm and
prominent central vein without cellular infiltration
(Fig. 7a). Whereas iron dextran overloaded mice demon-
strated various degrees of pathological changes including
ballooning degeneration, inflammation, loss of cellular
boundaries and hepatocellular necrosis (Fig. 7b). In con-
trast, SPW1 treated mice groups displayed attenuation
of pathogenicity and gradual reversal to normal cyto-
architecture, thus restoring the normal condition (Fig. 7c,
d, e respectively). Figure 7f represents liver sections of
the desirox-treated group with improved histology,
which is similar to the highest dose of SPW1. Another
detrimental effect of excess iron in the liver is deposition
of iron in the form of crystalline ferritins and amorphousFig. 2 ROS and RNS scavenging capabilities of SPW1. a Superoxide radical
scavenging, d Singlet oxygen radical scavenging, e Nitric oxide inhibition, f
(n = 6). *p < 0.05, **p < 0.01 and ***p < 0.001 vs. controlhemosiderin. Iron released from denatured ferritin, ferric
oxide (unused iron) as well as broken hemoglobin
formed a complex to store the iron known as hemosid-
erin. Perls’ Prussian blue is commonly used to detect its
deposition in liver tissue as blue patches. The liver sec-
tions from untreated iron overloaded mice demonstrated
increased hemosiderin deposition (Fig. 8b) compared to
normal mice (Fig. 8a). However, sections from the
treated mice groups demonstrated a gradual decrease in
hemosiderin deposition patches (Fig. 8c, d, e respect-
ively). The highest treatment dose exhibited a parallel
effect to the standard desirox-treated group (Fig. 8f ). Ac-
cumulated collagen in liver was also stained blue using
Masson’s trichrome. The microscopic observation sug-
gested that the liver section of control mice revealed
normal lobular architecture and distribution of collagen
(Fig. 9a). From the liver section of iron-overloaded mice,inhibition, b Hydroxyl radical inhibition, c Hypochlorous radical
Peroxynitrite radical scavenging. The results represent the mean ± S.D.
Fig. 3 In vitro iron chelation and reductive release of ferritin iron (Fe3+). a Iron chelation activity b Iron release from ferritin c Correlation between
iron released from ferritin with reducing power
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was destroyed and the nodules surrounded by accumu-
lated collagen indicating fibrous cirrhotic (Fig. 9b). How-
ever, after treatment with SPW1, a gradual decrease in
the degree of collagen deposition was observed (Fig. 9c,
d, e respectively). Here also, the treatment with the high-
est dose demonstrated a similar scenario when com-
pared to the standard desirox-treated group (Fig. 9f ).Phytochemical analysis
Qualitative determination of the phytochemicals ensured
the presence of phenolics, flavonoids, carbohydrates,
tannins, glycosides and terpenoids (Table 4). However,
quantitative analysis revealed that phenolics and glyco-
sides dominated over the other phytochemicals tested
(Table 4). HPLC analysis was done to identify the prob-
able bioactive compounds comparing the retention time
of the standard compounds. Major peaks with retention
time 3.5, 6.1, 50.12, 67.11 min appear on the HPLC
chromatogram. Among them, two peaks were identified
as tannic acid (3.5 min) and rutin (67.11 min) and other
peaks were remained unidentified (Fig. 10).Fig. 4 Removal of overloaded iron from mice liver and blood serum. a Iron
S100, S200, D) were treated as described in the ‘Experimental design’ se
**p ≤ 0.01, ***p ≤ 0.001 compared with the blank and #p < 0.05, ##p < 0.Discussion
Iron, one of the essential metals needed in our animal
kingdom, acts as the most common cofactor within the
oxygen handling biological machinery. However, iron in
excess, induced the overproduction of various free radi-
cals which is not always effectively normalized by the in-
ternal antioxidant defense machinery caused oxidative
stress related complications [11]. As our body lacks the
mechanism to transmute excess iron into any other sub-
stance, the only way to stop the detrimental effect of free
or partially liganded ‘iron’ is to make sure that all of its
six possible ligands are satisfied, whether by endogenous
chelators or those added from the diet or as pharmaceu-
ticals [12]. The ability of the antioxidant cum iron che-
lating agent to reduce the toxic effect or restore the
normal physiological condition is the index of its
hepato-ameliorating potential, which was noticeably
attained by the treatment with SPW1 in this present
study.
The antioxidant capacity of SPW1 was evaluated by
the decolourization of the ABTS · + and reducing prop-
erty of Fe3+ along with the scavenging property of
DPPH, stable free radicals. The assays produced anload in liver cell, b Level of ferritin in serum. Mouse groups (B, C, S50,
ction. Values are expressed as the mean ± SD of six mice. *p < 0.05,
01, ###p ≤ 0.001 compared with the control
Table 2 EC50 values of SPW1 in deferent assays
Name of the assays EC50 of SPW1 (mg/kg.b.w.)
Serum ferritin and liver iron levels
Serum Ferritin 177.491 ± 8.80
Liver Iron 81.15 ± 11.57
Serum Markers
ALAT 73.77 ± 4.19
ASAT 140.01 ± 16.99
ALP 159.32 ± 8.79
Bilirubin 263.18 ± 15.65
Antioxidant enzymes
SOD 27.99 ± 11.90
Catalase 84.29 ± 11.27
GST 90.84 ± 10.92
GSH 389.19 ± 25.68
Liver damage parameter
Lipid peroxidation content 223.10 ± 8.65
Protein carbonyl content 171.04 ± 11.40
Collagen content 205.59 ± 7.26
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tion as the total antioxidant assay, and the reducing
power is complimentary to each other. The excellent
DPPH radical scavenging power of the fraction gives an
initial idea about the radical scavenging property.
Different ROS such as superoxide, hydroxyl and sing-
let oxygen radicals induced several damages to different
biomolecules. Especially, superoxide radical is known as
an initiator to generate other free radicals such as hydro-
gen peroxide or singlet oxygen in the living system [13].
Hydroxyl radicals react with the lipid membrane and
produce proxy and alkoxy radical which in turn initiate
the chain reaction [14]. On the other hand RNS like ni-
tric oxide in excess causes various inflammatory diseases
and when it reacts with superoxide radical it produces
more toxic peroxynitrite radical that directly damages
different tissues [5, 15]. From the Fig. 2, it is clear that
SPW1 acted as a free radical scavenger, which effectivelyTable 3 The changes in ALAT, ASAT, ALP and Bilirubin levels after o
Treatment ALAT ASAT
Unit/L % change Unit/L % cha
B 14.42 ± 1.91 62.46 ± 6.32
C 64.60 ± 0.73 X3 347.88 234.91 ± 8.30 X3 276.1
S50 36.19 ± 1.16 X3Y3 150.91 170.49 ± 12.54 X3Y3 172.9
S100 27.47 ± 1.55 X3Y3 90.45 137.29 ± 17.82 X3Y3 119.8
S200 20.11 ± 0.16 X2Y3 39.41 97.62 ± 8.16 X3Y3 56.31
D 19.85 ± 0.79 X3Y3 37.59 88.06 ± 10.37 X2Y3 40.99
Mouse groups (B; C; S50, S100, S200, D) were treated as described in ‘Experimental
p < 0.001 significant difference from B group. Y1: p < 0.05, Y2: p < 0.01 and Y3: p < 0reduces the toxic effect of superoxide radical that in turn
neutralized the threat by different ROS and RNS. Fur-
ther, the radical scavenging property was supported by
the in vitro iron chelation property (Fig. 3a) of the frac-
tion as iron plays a crucial role in the generation of the
free radicals.
This excellent in vitro antioxidant, free radical scaven-
ging and iron chelation activity of the fraction leads us
to test the sample for it’s in vivo iron chelation as well as
hepato-ameliorating activity in Swiss albino mice. Sev-
eral previous studies suggest that iron in excess, induced
hepatic damage as the liver is the main storage site for
iron in our body [16]. To screen the hepatoprotective
potential, intraperitoneal iron-dextran injection followed
by oral treatment is a reliable method. Desirox (Generic
name-Deferasirox) used as positive control because it
binds to iron with high affinity in a 2:1 ratio with its tri-
dentate ligand. A study by Cheong et al. [17] showed
that Deferasirox is effective in reducing serum-ferritin
and liver iron concentration level in transfusional iron
overload patients. In addition, it also positively recovers
hematologic and hepatic function.
The leftover iron in our body is stored in the hepatic
cells as ferritin or hemosiderin [18]. Thus, measurement
of the iron levels in liver is used for diagnosis the iron-
load in iron overloaded disease. In contrast, ferritin, a
ubiquitous intracellular iron-binding protein in serum,
generally stores iron in a non-toxic ferric form and re-
leases it in a controlled fashion whenever needed [19].
So a level of serum ferritin is an indirect key marker re-
vealing the amount of hepatic iron content. The highest
dose of SPW1 significantly eliminated the surplus iron
justify its iron chelation property. On the other hand, to
overcome iron overloaded state, various readily available
iron chelator drugs were administered, but many of
them struggle with a narrow binding capacity for ferric
iron (Fe3+). The Fig. 3b signified that increasing concen-
trations of SPW1 significantly released iron (Fe3+) from
ferritin with time and the correlation between the per-
centage of iron released from ferritin and the reducing
power (Fig. 3c) was quite significant (R2 = 0.804). Thisral therapy with SPW1
ALP Bilirubin
nge Unit/L % change mg/dl % change
84.62 ± 3.48 1.58 ± 0.10
3 252.63 ± 4.92 X3 198.56 3.15 ± 0.18 X3 99.67
7 181.71 ± 6.18 X3Y3 114.74 2.42 ± 0.25 X2Y2 53.43
2 149.48 ± 7.02 X3Y3 76.66 2.18 ± 0.12 X3Y3 38.41
125.08 ± 5.93 X3Y3 47.81 1.99 ± 0.13 X3Y3 26.22
114.97 ± 6.13 X3Y3 35.87 1.72 ± 0.14 X1Y3 8.92
design’ section. Values are mean ± SD (n = 6). X1: p < 0.05, X2: p < 0.01 and X3:
.001 significant difference from C group
Fig. 5 Restoration of liver antioxidant enzyme levels after treatment with SPW1. a SOD, b Catalase, c GST, d GSH. Mouse groups (B, C, S50, S100,
S200, D) were treated as described in the ‘Experimental design’ section. Values are expressed as the mean ± SD (n = 6). *p < 0.05, **p≤ 0.01,
***p ≤ 0.001 compared with the blank and #p < 0.05, ##p≤ 0.01, ###p≤ 0.001 compared with the control
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the excess iron by reducing it from its ferric form.
Levels of serum enzyme are checked in the clinical
diagnosis to determine the condition of various diseases
and tissue injury [20, 21]. As these enzymes are predom-
inantly found in the hepatic cell, liver damage due to ex-
cess iron leads to the release of these intracellularFig. 6 SPW1 treatment gradually reduced the elevated levels of liver dama
c Collagen content. Mouse groups (B, C, S50, S100, S200, D) were treated a
the mean ± SD (n = 6). **p≤ 0.01, ***p≤ 0.001 compared with the blank anenzymes into the blood [22] as evident by increased
serum parameters (Table 3). The administration of
SPW1 has reduced the increased level of the serum
marker enzymes almost similar to the standard desirox.
This result indicated towards its healing capabilities of
hepatic parenchyma and regeneration of hepatocyte as
well as its functional efficiency [23].ge parameters. a Lipid peroxidation levels, b Protein carbonyl content,
s described in ‘Experimental design’ section. Values are expressed as
d ###p ≤ 0.001 compared with the control
Fig. 7 Morphological evaluation of liver sections, stained with hematoxylin and eosin at × 400. a Control mice liver with normal cyto-structure. b
Iron-overloaded liver section showed disrupted cell membrane, inflammation (I), and necrosis (N). c Liver section from the S50 group showed
improved histology with portal inflammation (PI). d Liver section from the S100 group. e Liver section from the S200 mouse group. f Cellular
morphology is almost similar to Desirox-treated liver sections
Fig. 8 Visual confirmation of iron removal potential of SPW1 by liver sections stained with Perls’ Prussian blue at × 400. a Control mice with
minimal hemosiderin deposition patches (very low). b Excess blue patches denote iron-overloaded condition in mice. c Liver section from S50
mouse group. d Liver section from S100 mouse group e Liver section from S200 mouse group. All three groups (C, D, E) showed gradual reduction of
the blue patches. f Desirox-treated liver section with lesser blue patches
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Fig. 9 Reduction of liver fibrosis observed by staining the liver sections with Masson’s Trichrome × 100. a Control mice showed no sign of
fibrosis. b Iron-intoxicated mice displayed elongated fibrous septa and collagen accumulation (blue). c Liver section from S50 with lesser blue
patches, d Liver section from S100 group e S200 demonstrates a nearly negligible collagen accumulation and healthy liver. f Desirox-treated
liver section
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are armed with a group of intracellular antioxidant en-
zymes such as GST, SOD, CAT and the small compound
GSH, which act as a first line of defenses. So estimation
of the levels of these antioxidant enzymes is a proper in-
direct way to assess pro-oxidant-antioxidant combat in
tissues [24]. Iron-overloaded condition stimulates the
oxidative stress followed by the reduction of the levels of
antioxidant enzymes. Oral treatments significantly re-
store the levels of the entire antioxidant enzymes to nor-
mal more readily than used drug desirox. This result
signified the fraction SPW1 as a potent antioxidant
agent both in vitro as well as in vivo condition.
The iron-overloaded condition increases the disease
related serum enzymes and reduces the activity of cells
antioxidant defense machinery, ultimately leading to
liver tissue damage. The lipid bilayer is destroyed by hy-
droxyl radical (lipid peroxidation) and results to end
products such as malondialdehyde (MDA) which in turnTable 4 Phytochemical analysis of SPW1
Sample Tests Phytochemicals
Phenol Flavonoid Tannin Carboh
SPW1 Qualitative + + + +
Quantitative 44.23 ± 1.08 16.65 ± 0.26 6.36 ± 0.06 10.96 ±
Anthra- Anthraquinone, Sap-Saponin, Terpen-Terpenoids, Triterpen- Triterpenoids. T
(mg/100 mg extract quercetin equivalent), Tannin (mg/100 mg extract catechin equ
(mg/100 mg extract Rutin equivalent), “+” represents presence of the phytoconstitu
Not Determinedactivate the stellate cells to initiate liver fibrosis [25–27].
After liver injury, the production of collagen predominates
over hepatocellular regeneration as an immediate healing
response, thereby occupying the injured areas instead of
destroyed hepatocytes. Collagen content is therefore con-
sidered to be a major marker of liver fibrosis and hepato-
toxicity [28]. Iron-induced liver pathogenicity also leads to
the oxidation of various important structural and func-
tional proteins and forms protein carbonyls. Thus, it
serves as a marker of oxidative stress and leads to the on-
set/development of various diseases including cystic fibro-
sis and ulcerative colitis [29]. The chelation of excess iron
by SPW1 subsequently reduced the liver damage and liver
fibrosis indicating its hepato-ameliorating potency as
shown in Fig. 6 which is again better than desirox.
Above all, liver biopsy is the ultimate standard to de-
termine the degree of tissue damage and fibrosis along-
side other pathological tests. The live sections stained
with hematoxylin and eosin exhibited various degrees ofydrate Glycoside Alkaloid Anthra Sap Terpen Triterpen
+ - - - + -
0.14 31.48 ± 0.09 ND ND ND ND ND
otal phenolics (mg/100 mg extract gallic acid equivalent), Total flavonoids
ivalent), Carbohydtrate (mg/100 mg extract glucose equivalent), Glycoside
ent; “-” represents absence of the phytoconstituent. “ND” represents
Fig. 10 HPLC analysis of SPW1. The marked peaks denote the retention of peaks matched with the retention of the respective standard
phytochemicals in the same condition
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in iron overloaded condition, but treatment with SPW1
reduced the tissue damage that also supported the result
of the restoration of serum enzyme and antioxidant en-
zyme levels. Perls’ Prussian blue staining revealed the
visual confirmation of iron chelation property of the test
sample along with the liver iron content and serum
ferritin content. On the other hand, Masson’s trichrome
staining disclosed the reduction of liver fibrosis as the
collagen content gradually decreased with the increasing
doses of SPW1, which also confirmed the anti-fibrotic
effect of the fraction along with the test for collagen
content.
The presence of different phytochemicals confirmed
the backbone of the bioactivity of SPW1. The adequate
amounts of phenolic and glycosides in SPW1 revealed
that the fractionation procedure mainly concentrated the
glycosidic phenolics and flavonoids from the water frac-
tion. This observation was also confirmed by the HPLC
analysis, where only two compounds were identified,
one of them is tannic acid (phenolic) and other is rutin
(glycoside) and the major peak at 50.12 min is probably
the combined peak of the other glycoside compounds.
Literature survey revealed that, tannic acid, rutin and
other glycosides are potent antioxidants, metal chelators
thereby inhibiting lipid peroxidation, which also support
their hepato-ameliorating potentials [30, 31]. Especially,
rutin, a flavonoid glycoside, is found in wide variety of
plants exhibit powerful anti-inflammatory activity along
with its antioxidant, metal chelation and protective ef-
fects on hepatotoxicity [32].Conclusions
From the present study, it could be concluded that
SPW1 can be used as a favorable candidate to cure iron
overload-mediated oxidative stress and hepatotoxicity as
it is capable of both scavenging the free radicals and
chelate the excess iron in the body. It also further con-
cluded that the activity of SPW1 is mainly due to the
glycosidic phenolic and flavonoid compounds present in
it. Though, further studies are warranted to determine
the exact mechanism(s) involved in the hepatoprotective
activity of the SPW1 along with the complete
characterization of all bioactive compounds present
in this fraction.
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